Fixed Dose Heparin Study
Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism
About this trial
This is an interventional treatment trial for Venous Thromboembolism focused on measuring Unfractionated Heparin, Low Molecular Weight Heparin, Venous Thromboembolism, APTT, Treatment
Eligibility Criteria
Inclusion Criteria: A diagnosis of acute venous thromboembolism (VTE,DVT and /or PE) Exclusion Criteria: Contraindication to subcutaneous (sc) route of administration (eg:shock (evidence of poor peripheral perfusion), major surgery within 48 hours) Active Bleeding process Comorbid condition limiting expected survival to less than 3 months Current treatment with therapeutic dose of UFH, LMWH, danaparoid sodium, or a direct thrombin inhibitor for more than 48 hours Currently on long term warfarin or heparin therapy Allergy to heparin or history of heparin induced thrombocytopenia Currently pregnant Contraindication to contrast media (eg: allergy or creatinine >200 umol/L). Currently enrolled or will be enrolled in a competing study Geographically inaccessible for follow-up assessment
Sites / Locations
- Hamilton Health Sciences-General Campus
- Hamlton Health Sciences -McMaster Campus
- St. Joseph's Healthcare Centre
- Hamilton Health Sciences-Henderson Campus
- McGill University Health Centre
- CHA Pavillon du Saint-Sacrement
- Auckland Hospital
- Middlemore